Newron Pharmaceuticals S.p.A. (NP5.DE) XETRA

25.50

+1.3(+5.37%)

Updated at December 23 05:35PM

Currency In EUR

Valuation

Market Cap174.68M
Enterprise Value218.21M
P/E Ratio20.05
PEG Ratio0.34
Price/Sales Ratio8.48
Price/Book Ratio320.96
Enterprise/Revenue8.91
Enterprise/EBITDA15.27

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin0.42
Operating Margin0.59

Management Effectiveness

Return On Assets0.41
Return On Equity16.66

Income Statement

Revenue51.39M
Revenue/Share3
Gross Profit51.39M
EBITDA25.94M
Net Income15.84M
Diluted EPS0.85

Balance Sheet

Total Cash43.2M
Total Cash/Share2.16
Total Debt52.57M
Total Debt/Equity33.23
Current Ratio1.51
Book Value Per Share0.08

Price History

52-Week Change170.99
52-Week High25.95
52-Week Low6.03
Moving Average 50 Days18.01
Moving Average 200 Days11.02

Statistics

Average Volume6,705
Shares Outstanding19.96M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A